Amylyx ALS Drug: ICER Revised Evidence Report Casts Doubt On Firm’s New Data Analyses

 
• By Cathy Kelly
  
ICER Analysis And AMX0035 Payment Policy: New Ice Bucket Challenge? • Source: Shutterstock

More from Health Technology Assessment

More from Market Access